Full-Time

Automation Pharmacy Technician 4

Intravenous Compounding

Posted on 12/15/2025

Omnicell

Omnicell

1,001-5,000 employees

Medication management and pharmacy automation platform

No salary listed

Sarasota, FL, USA

In Person

On-site required; daily commute to Sarasota; travel for training.

Category
Medical, Clinical & Veterinary (2)
,
Required Skills
Inventory Management
Requirements
  • High school diploma or GED
  • Current non-expired PTCB Certification or via National Healthcareer Association a Certified Pharmacy Technician / EXCPT
  • Current State Pharmacy Technician Registration / License for the State of Florida (if required/applicable)
  • Working knowledge of IV compounding
Responsibilities
  • Perform IV automation tasks in an aseptic, error free manner, consistent with standard operating procedures.
  • Perform daily, weekly, and monthly IV automation equipment cleaning and maintenance.
  • Follow Safe Handling of Hazardous Drugs procedures when handling medications.
  • Identify / order medications to ensure medication inventories are at optimal levels.
  • Monitor and order consumable supplies required for the operation of the equipment.
  • Perform basic troubleshooting and standard maintenance of IV automation equipment and report unresolved equipment issues to the IV technical assistance center.
  • Complete fingertip and media fill sampling.
  • Maintain a high level of communication with pharmacy operations manager and customer, to ensure proactive, solution-oriented problem identification and resolution.
  • Maintain a high level of customer satisfaction by aligning the Pharmacy Services Program to provide customer-focused support emphasizing quality, professionalism, and responsiveness, by acting as liaison between Omnicell and customer to assist with customer concerns.
  • Conduct training and ensure completion of all required documents and compliance with all Pharmacy Services procedures and policies.
  • Maintain fiscal responsibility for work-related expenses, complete expense reports, adhere to corporate card procedures, per Omnicell travel policies.
  • Comply with reasonable procedures, policies and guidelines established by the Customer facility.
  • Maintain national certification and all state required credentialing.
  • Act as a resource or SME, for Omnicell team members, providing training and/or assistance either on site or remotely to ensure optimal workflow.
Desired Qualifications
  • Specialized Knowledge / Skills: Good organizational skills in a fast-paced environment.
  • Demonstrate customer service skills.
  • Strong communication and problem-solving skills.
  • Ability to work with mechanical equipment.
  • Working knowledge of computer hardware, Microsoft Windows, Excel, and PowerPoint.
  • A self-starter who is able to work independently and follow a detailed plan.
  • Excellent interpersonal communication skills with the ability to work well with customers and with employees at various levels.
  • One year of IV Compounding experience.
  • Proficient in the use of PPE and hand hygiene techniques.
  • Working knowledge of sterile environment requirement.
  • Completed an accredited Pharmacy Technician Training Program.
  • 2 years previous experience in hospital pharmacy automation.
  • Basic Troubleshooting Skills with automation devices.
  • Automation implementation experience.

Omnicell provides medication management solutions and adherence tools for health systems and pharmacies, combining pharmacy automation devices with cloud-based software to automate dispensing, manage inventory, and support patient adherence. The products mix hardware and a cloud platform that coordinates dispensing, inventory control, and clinical data through dashboards and analytics. Compared with competitors, Omnicell emphasizes a cloud-first software approach with a clear path to software-as-a-service and a hybrid direct-plus-partner sales model for end-to-end pharmacy automation and data services. Its goal is to realize the Autonomous Pharmacy by using automation and intelligent services to improve pharmacy care and patient outcomes while building recurring revenue.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Mountain View, California

Founded

1992

Your Connections

People at Omnicell who can refer or advise you

Direct Contacts
Warm Intros
Hiring Managers
University Alumni
Simplify Jobs

Simplify's Take

What believers are saying

  • Titan XT targets a $2.5 billion installed-base replacement opportunity.
  • Recurring revenue is rising, with 2026 annual recurring revenue guided to $680–700 million.
  • Mandoli's May 2026 hire strengthens specialty pharmacy and 340B expansion execution.

What critics are saying

  • BD and other rivals can win hospital automation budgets through bundled contracts.
  • Hospital capital freezes delay Titan XT shipments and software conversion timing.
  • Tariffs add about $12 million of 2026 costs, pressuring hardware margins.

What makes Omnicell unique

  • Omnicell combines medication automation, software, and services across hospitals and pharmacies.
  • OmniSphere centralizes cloud-native pharmacy workflows and real-time inventory visibility.
  • Specialty Pharmacy Services and 340B expand Omnicell beyond cabinet hardware.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Mar 5th, 2026
Omnicell's Titan XT cabinet launch divides analysts on $1.3B revenue outlook

Omnicell's analyst narrative centres on its Titan XT cabinet system and a potential hospital replacement cycle, though opinions diverge sharply on timing. The modelled fair value holds at $57.43 amid mixed price target revisions. BofA, Benchmark and KeyBanc have taken bullish stances, with KeyBanc upgrading to Overweight at $60, citing competitive wins and a cabinet refresh cycle. Conversely, Piper Sandler cut its target by $14, flagging execution and timing risks around the same Titan XT story. Omnicell issued Q1 2026 revenue guidance of $300 million to $310 million and full-year guidance of $1.215 billion to $1.255 billion. The company has launched Titan XT in the US, with international rollout expected later in 2026.

Yahoo Finance
Feb 28th, 2026
Omnicell targets $2.4B revenue by 2031 with shift to AI-driven pharmacy automation

Omnicell, Inc. is transitioning from hardware-driven revenue to a software and services model, aiming to double revenue from $1.18 billion to $2.4 billion by 2031, according to a bullish thesis on Danny's Substack. The company is expanding through strategic acquisitions like ANiGENT and developing its "Autonomous Pharmacy" vision using AI and robotics. The healthcare automation firm benefits from high switching costs, over 900 patents and a large installed base. Recurring revenue is approaching 50% of total revenue, with margins expected to expand from low teens to mid-20s. Bulls believe the market currently undervalues Omnicell as a hardware vendor, creating potential for significant rerating as it shifts towards healthcare IT, with shares trading at $38.61 as of 18 February.

Yahoo Finance
Feb 2nd, 2026
Omnicell beats Q3 revenue estimates by 5%, stock surges 64% since earnings report

Omnicell, a provider of medication management automation and adherence tools for healthcare systems and pharmacies, reported third-quarter revenues of $310.6 million, up 10% year on year and exceeding analysts' expectations by 5%. The company also beat earnings per share estimates. "We are pleased with the strong financial performance delivered in the third quarter," said Randall Lipps, Omnicell's chairman, president and chief executive officer. The stock has risen 64% since reporting results and currently trades at $48.49. The healthcare technology for providers sector faces mixed conditions, with opportunities from AI-driven tools and government digitisation incentives offset by challenges including long sales cycles, slow adoption rates, and tightening hospital budgets. The four companies tracked in this sector reported satisfactory third-quarter results overall, though share prices have declined 5.3% on average since earnings.

Specialty Pharmacy Continuum
Aug 18th, 2025
Texas Children's Hospital Adopts RFID for OR Med Management

This May, medication and supply management technology company Omnicell launched a new radio frequency identification (RFID)-enabled device to manage medications in the operating room.

StreetInsider
Mar 24th, 2025
Omnicell (OMCL) appoints Perry Genova as CTO

Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming the pharmacy and nursing care delivery model, today announced that Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, effective March 31, 2025.

INACTIVE